Short-term tranexamic acid treatment reduces in-hospital mortality in aneurysmal sub-arachnoid hemorrhage: A multicenter comparison study

Antifibrinolytic therapy in aneurysmal subarachnoid hemorrhage increases the risk for deep venous thrombosis: A case–control study

(2015) Paul M. Foreman et al.   CLINICAL NEUROLOGY AND NEUROSURGERY

Time intervals from subarachnoid hemorrhage to rebleed

(2014) M. R. Germans et al.   JOURNAL OF NEUROLOGY

Time intervals from aneurysmal subarachnoid hemorrhage to treatment and factors contributing to delay

(2013) Menno R. Germans et al.   JOURNAL OF NEUROLOGY

Ultra-early tranexamic acid after subarachnoid hemorrhage (ULTRA): study protocol for a randomized controlled trial

(2013) Menno R Germans et al.   Trials

An Examination of Aneurysm Rerupture Rates with Epsilon Aminocaproic Acid

(2012) Albert J. Schuette et al.   Neurocritical Care

Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage

(2012) E. Sander Connolly et al.   STROKE

Antifibrinolytic therapy in the management of aneurismal subarachnoid hemorrhage revisited. A meta-analysis

(2011) Thomas Gaberel et al.   ACTA NEUROCHIRURGICA

Delays in treating patients with good grade subarachnoid haemorrhage in London

(2011) Jonathan N. Lamb et al.   BRITISH JOURNAL OF NEUROSURGERY

Rebleeding After Aneurysmal Subarachnoid Hemorrhage

(2011) R. M. Starke et al.   Neurocritical Care

Definition of Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage as an Outcome Event in Clinical Trials and Observational Studies

(2010) Mervyn D.I. Vergouwen et al.   STROKE

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies

(2008) Erik von Elm et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Impact of a Protocol for Acute Antifibrinolytic Therapy on Aneurysm Rebleeding After Subarachnoid Hemorrhage

(2008) Robert M. Starke et al.   STROKE